Vaccination against hepatitis delta virus infection: Studies in the woodchuck (Marmota monax) model

Intervirology

Volumn 44, Issue 2-3, 2001, Pages 154-161

  Fiedler, Melanie ^a   Roggendorf, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

DNA immunization; Hepatitis delta virus; Protein immunization; Vaccinia virus; Woodchuck hepatitis virus

Indexed keywords

DNA VACCINE; EPITOPE; GAG PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS D VACCINE; HEPATITIS DELTA ANTIGEN; HEPATITIS VACCINE; INTERLEUKIN 12; INTERLEUKIN 18; PLASMID DNA; PROTEIN P27; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VACCINIA VACCINE; VIRUS DNA;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACULOVIRUS; CARBOXY TERMINAL SEQUENCE; CHRONICITY; CYTOTOXIC LYMPHOCYTE; DELTA AGENT HEPATITIS; DISEASE COURSE; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION; HEPATITIS B; HEPATITIS DELTA VIRUS; IMMUNOMODULATION; INFECTION PREVENTION; LIVER DISEASE; MODEL; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION; TREATMENT OUTCOME; VACCINATION; VIRUS CARRIER; WOODCHUCK; YEAST;

ANIMALS; CARRIER STATE; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HEPATITIS D; HEPATITIS DELTA VIRUS; MARMOTA; SUPERINFECTION; VACCINES, DNA; VACCINES, SUBUNIT; VACCINIA VIRUS; VIRAL HEPATITIS VACCINES;

DELTA VIRUS; ESCHERICHIA COLI; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; MARMOTA MONAX; UNIDENTIFIED BACULOVIRUS; VACCINIA; VACCINIA VIRUS; WOODCHUCK HEPATITIS B VIRUS;

EID: 0034889152     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050042     Document Type: Article

References (54)

1. Delta hepatitis agent Structural and antigenic properties of the delta-associated particle
2. The molecular biology of hepatitis delta virus: Recent advances
3. Genetic organization and replication strategy of hepatitis delta virus
4. Immunoblot analysis demonstrates that the large and the small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences
5. A specific base transition occurs on replicating hepatitis delta virus RNA
6. Recent developments in hepatitis delta virus research
7. Initiation of replication of he human hepatitis delta virus genome from cloned DNA Role of delta-antigen
8. Role of the two forms of hepatitis delta antigen: Evidence for a mechanis of self-limiting genome replication
9. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus
10. Hepatitis delta virus infection
11. Expression of he hepatitis delta virus large and small antigens in transgenic mice
12. Human CD4+T-cell response to hepatitis delta virus Identification of multiple epitopes and characterization of T-helper cytokine profiles
13. Biology and characterization of the delta agent
14. Epidemiology of hepatitis delta virus: Overview
15. WHO: Lack of evidence that hepatitis B vaccine causes multiple sclerosis
16. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees
17. Chronic hepatitis D virus (HDV) in hepatitis B virus carrier chimpanzees experimentally superinfected with HDV
18. Transmission of the hepatitis B virus associated delta agent to he eastern woodchuck
19. Acute and chronic delta infection in he woodchuck
20. Experimental hepatitis delta virus infection in the animal model
21. Different outcome of chronic hepatitis delta virus infection in woodchucks
22. Dose dependence of CTL precursor frequency by a DNA vaccine and correlation with protective immunity against influenza virus challenge
23. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein
24. Hepatitis B virus antigens made in microbial cells immunise against viral infection
25. Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects hepatitis virus infection
26. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
27. Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro
28. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys
29. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection
30. Peptide vaccines for viral diseases
31. Induction of high levels of antibodies recognizing the neutralizing epitope ELDKWA and the D-or K-position-mutated epitopes by candidate epitope vaccines against HIV-1
32. 48-Mer synthetic peptide analogue of the hepatitis virus 'a 'determinant induces an anti-HBs anti-body response after a single injection
33. Hepatitis delta antigen Antigenic structure and humoral immune response
34. Gerin: Modulation of hepatitis delta virus infection by vaccination with synthetic peptides A preliminary study in the woodchuck model
35. Immunization of woodchucks (Marmota monax) with DNA vaccine containing HDV-p24 modulates hepatitis delta virus superinfection after challenge
36. Immunisation of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection
37. Immunisation of woodchucks with hepatitis delta antigen expressed by recombinant vaccinia and baculovirus controls HDV superinfection
38. Immunogenic domains of hepatitis delta virus antigen: Peptide mapping of epitopes recognised by human and woodchuck antibodies
39. Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax)with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus
40. Towards a vaccine for the prevention of hepatitis delta virus superinfection in HBV carriers
41. CpG oligonucleotides act as adjuvant that switch on T helper 1 (Th1)immunity
42. Induction of Th1 and Th2 immunity in neonatal mice
43. Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen
44. The effects of using recombinant vaccinia viruses expressing either large or small HDAg to protect woodchuck hepadnavirus carriers from HDV superinfection
45. Characterization of cellular immune responses against hepatitis delta virus antigens after DNA-based immunization in mice
46. DNA-based immunization produces TH1 immune responses to hepatitis delta virus in a mouse model
47. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses
48. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
49. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection
50. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen supresses WHV infection
51. Inhibition of HDV RNA replication in vitro by ribavirin and suramin
52. Expression and purification of woodchuck tumour necrosis factor alpha
53. Molecular cloning of the woodchuck cytokines TNF-α, IFN-γ and IL-6
54. Cytokine and hepatitis B virus DNA co-immunization enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice